Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent chronic liver disorders worldwide. It is closely associated with metabolic syndrome components, including type 2 diabetes, hyperlipidaemia and obesity. To date, no effective drug treatment is available for NAFLD but several clinic...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioExcel Publishing Ltd
2023-04-01
|
| Sarja: | Drugs in Context |
| Aiheet: | |
| Linkit: | https://www.drugsincontext.com/silymarin-treatment-and-reduction-of-liver-enzyme-levels-in-non-alcoholic-fatty-liver-disease-a-case-report/ |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|